Pharming Group N.V. - ADS, each representing 10 ordinary shares (PHAR)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Apr 2, 2026Investment Snapshot
- P/B of 52.07 — trading above book value
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -5.4%
- Revenue growing at 21% annually
Pharming Group N.V. - ADS, each representing 10 ordinary shares (PHAR) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $11.5 billion . Key value metrics: P/B ratio 52.07, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Pharming Group N.V. - ADS, each representing 10 ordinary shares — Fundamental Analysis Summary
On financial health, PHAR shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -5.4% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.00.
StockPik's composite Value Score for PHAR is 27/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PHAR reports a high gross margin of 88.1% (sector average: 33.5%) and a negative operating margin of -2.9%.
PHAR shows revenue growing at 21% year-over-year, with earnings declining at 12%.